Axa’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-93,365
Closed -$371K 1374
2019
Q3
$371K Sell
93,365
-2,244
-2% -$13K ﹤0.01% 1146
2019
Q2
$692K Sell
95,609
-375
-0.4% -$2.56K ﹤0.01% 1039
2019
Q1
$634K Hold
95,984
﹤0.01% 1066
2018
Q4
$687K Hold
95,984
﹤0.01% 1033
2018
Q3
$1.83M Hold
95,984
0.01% 897
2018
Q2
$5.43M Sell
95,984
-295
-0.3% -$15K 0.02% 635
2018
Q1
$4.07M Hold
96,279
0.02% 703
2017
Q4
$5.15M Hold
96,279
0.02% 643
2017
Q3
$4.29M Hold
96,279
0.02% 651
2017
Q2
$4.68M Hold
96,279
0.02% 621
2017
Q1
$6.97M Buy
96,279
+353
+0.4% +$23.3K 0.03% 522
2016
Q4
$5.49M Buy
95,926
+28,526
+42% +$2.61M 0.03% 553
2016
Q3
$8.63M Buy
67,400
+8,038
+14% +$1.03M 0.04% 443
2016
Q2
$7.4M Buy
59,362
+818
+1% +$94K 0.03% 466
2016
Q1
$4.89M Buy
58,544
+20,140
+52% +$1.66M 0.02% 571
2015
Q4
$3.8M Buy
38,404
+152
+0.4% +$16.3K 0.02% 632
2015
Q3
$4.69M Buy
38,252
+1,037
+3% +$141K 0.02% 589
2015
Q2
$5.71M Buy
37,215
+408
+1% +$67.3K 0.02% 561
2015
Q1
$6.28M Buy
36,807
+194
+0.5% +$29.4K 0.03% 525
2014
Q4
$5.6M Buy
36,613
+123
+0.3% +$15.4K 0.02% 522
2014
Q3
$3.87M Buy
36,490
+680
+2% +$94.8K 0.02% 595
2014
Q2
$5.45M Sell
35,810
-722
-2% -$96.1K 0.02% 521
2014
Q1
$4.7M Buy
36,532
+1,183
+3% +$184K 0.02% 540
2013
Q4
$6.17M Buy
35,349
+864
+3% +$148K 0.03% 480
2013
Q3
$5.56M Buy
34,485
+127
+0.4% +$20K 0.03% 494
2013
Q2
$4.56M Buy
+34,358
New +$4.85M 0.02% 496

Other funds holding ELGX

Axa's ELGX Position: Q4 2019 in Review

Axa sold out of Endologix Inc (ELGX) in Q4 2019, closing a stake of 93,365 shares — an estimated $371K sold.

Axa first reported a position in ELGX in Q2 2013 and held it in 26 quarters. The position peaked at $8.63M in Q3 2016. 57 funds tracked by Wall St. Rank hold ELGX as of Q4 2019.

  • Axa reported no remaining Endologix Inc position as of Q4 2019 after selling out during the quarter.
  • Axa sold 93,365 Endologix Inc shares in Q4 2019, an estimated $371K.
  • Axa first reported a position in Endologix Inc in Q2 2013 and held it in 26 quarters.
  • Axa's Endologix Inc position peaked at $8.63M in Q3 2016.
  • 57 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.